Bertrand Coiffier

59.2k total citations · 8 hit papers
486 papers, 33.6k citations indexed

About

Bertrand Coiffier is a scholar working on Pathology and Forensic Medicine, Oncology and Genetics. According to data from OpenAlex, Bertrand Coiffier has authored 486 papers receiving a total of 33.6k indexed citations (citations by other indexed papers that have themselves been cited), including 370 papers in Pathology and Forensic Medicine, 207 papers in Oncology and 176 papers in Genetics. Recurrent topics in Bertrand Coiffier's work include Lymphoma Diagnosis and Treatment (367 papers), Chronic Lymphocytic Leukemia Research (163 papers) and Viral-associated cancers and disorders (91 papers). Bertrand Coiffier is often cited by papers focused on Lymphoma Diagnosis and Treatment (367 papers), Chronic Lymphocytic Leukemia Research (163 papers) and Viral-associated cancers and disorders (91 papers). Bertrand Coiffier collaborates with scholars based in France, United States and Germany. Bertrand Coiffier's co-authors include Gilles Salles, Hervé Tilly, Christian Gisselbrecht, Catherine Thiéblemont, Éric Lepage, Philippe Gaulard, Félix Reyes, Raoul Herbrecht, Josette Brière and P Lederlin and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and Blood.

In The Last Decade

Bertrand Coiffier

478 papers receiving 32.8k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

CHOP Chemotherapy plus Rituximab Compared with CHOP Alone in Elderly Patients with Diffuse Large-B-Cell Lymphoma

2002 4.0k citations Bertrand Coiffier, Éric Lepage et al. profile →
Revised Response Criteria for Malignant Lymphoma

2007 3.2k citations Bertrand Coiffier, Emanuele Zucca et al. Journal of Clinical Oncology profile →
Autologous Bone Marrow Transplantation as Compared with Salvage Chemotherapy in Relapses of Chemotherapy-Sensitive Non-Hodgkin's Lymphoma

1995 1.8k citations Thierry Philip, Bertrand Coiffier et al. profile →
Long-Term Results of the R-CHOP Study in the Treatment of Elderly Patients With Diffuse Large B-Cell Lymphoma: A Study by the Groupe d'Etude des Lymphomes de l'Adulte

2005 1.1k citations Pierre Feugier, Catherine Sebban et al. Journal of Clinical Oncology profile →
Long-term outcome of patients in the LNH-98.5 trial, the first randomized study comparing rituximab-CHOP to standard CHOP chemotherapy in DLBCL patients: a study by the Groupe d'Etudes des Lymphomes de l'Adulte

2010 1.1k citations Bertrand Coiffier, Catherine Thiéblemont et al. Blood profile →
Phase III Study to Evaluate Temsirolimus Compared With Investigator's Choice Therapy for the Treatment of Relapsed or Refractory Mantle Cell Lymphoma

2009 485 citations Georg Heß, Raoul Herbrecht et al. Journal of Clinical Oncology profile →
Results From a Pivotal, Open-Label, Phase II Study of Romidepsin in Relapsed or Refractory Peripheral T-Cell Lymphoma After Prior Systemic Therapy

2012 485 citations Bertrand Coiffier, Barbara Pro et al. Journal of Clinical Oncology profile →
Pralatrexate in Patients With Relapsed or Refractory Peripheral T-Cell Lymphoma: Results From the Pivotal PROPEL Study

2011 439 citations Owen A. O’Connor, Barbara Pro et al. Journal of Clinical Oncology profile →

Peers

Countries citing papers authored by Bertrand Coiffier

Since Specialization

Citations

This map shows the geographic impact of Bertrand Coiffier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bertrand Coiffier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bertrand Coiffier more than expected).

Fields of papers citing papers by Bertrand Coiffier

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bertrand Coiffier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bertrand Coiffier. The network helps show where Bertrand Coiffier may publish in the future.

Co-authorship network of co-authors of Bertrand Coiffier

This figure shows the co-authorship network connecting the top 25 collaborators of Bertrand Coiffier. A scholar is included among the top collaborators of Bertrand Coiffier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bertrand Coiffier. Bertrand Coiffier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Pharmacokinetics, efficacy and safety of the rituximab biosimilar CT-P10 2017 ·Expert Review of Clinical Pharmacology ·Bertrand Coiffier	18
2	Impact of BMI and Gender on Outcomes in DLBCL Patients Treated with R-CHOP: A Pooled Study from the LYSA 2014 ·Clémentine Sarkozy, Nicolas Mounier, Alain Delmer, Achiel Van Hoof, (unknown), (unknown), Marie Maerevoet, (unknown), Richard Delarue, Michel Fabbro, Bertrand Coiffier	15
3	Addition of Rituximab to Chlorambucil Produces Superior Event-Free Survival in the Treatment of Patients With Extranodal Marginal-Zone B-Cell Lymphoma: 5-Year Analysis of the IELSG-19 Randomized Study 2013 ·Journal of Clinical Oncology ·Emanuele Zucca, Annarita Conconi, Daniele Laszlò, Armando López‐Guillermo, Réda Bouabdallah, Bertrand Coiffier, Catherine Sebban, Fabrice Jardin, Umberto Vitolo, Franck Morschhauser, Stefano Pileri, Christiane Copie‐Bergman, Elı́as Campo, Andrew Jack, Irene Floriani, Peter Johnson, Maurizio Martelli, Franco Cavalli, Giovanni Martinelli, Catherine Thiéblemont	148
4	Safety and Clinical Activity of a Combination Therapy Comprising Two Antibody-Based Targeting Agents for the Treatment of Non-Hodgkin Lymphoma: Results of a Phase I/II Study Evaluating the Immunoconjugate Inotuzumab Ozogamicin With Rituximab 2013 ·Journal of Clinical Oncology ·Luis Fayad, Fritz Offner, Mitchell R. Smith, Gregor Verhoef, Peter Johnson, Jonathan L. Kaufman, A. Z. S. Rohatiner, Anjali S. Advani, James M. Foran, Georg Heß, Bertrand Coiffier, Myron S. Czuczman, Eva Giné, Simon Durrant, Michelle Kneissl, Kenneth T. Luu, Steven Y. Hua, Joseph Boni, Erik Vandendries, Nam H. Dang	119
5	A Dose-Escalation Study of SAR3419, an Anti-CD19 Antibody Maytansinoid Conjugate, Administered by Intravenous Infusion Once Weekly in Patients with Relapsed/Refractory B-cell Non-Hodgkin Lymphoma 2013 ·Clinical Cancer Research ·Vincent Ribrag, Jehan Dupuis, Hervé Tilly, Franck Morschhauser, Fabrice Lainé, Roch Houot, Corinne Haïoun, (unknown), Andréa Varga, John M. Lambert, Laurence Hatteville, (unknown), Anne Caron, Sandrine Payrard, Bertrand Coiffier	79
6	Results From a Pivotal, Open-Label, Phase II Study of Romidepsin in Relapsed or Refractory Peripheral T-Cell Lymphoma After Prior Systemic Therapy breakdown → 2012 ·Journal of Clinical Oncology ·Bertrand Coiffier, Barbara Pro, H. Miles Prince, Francine M. Foss, Lubomir Sokol, Matthew Greenwood, Dolores Caballero, Peter Borchmann, Franck Morschhauser, Martin Wilhelm, Lauren Pinter‐Brown, Swaminathan P. Iyer, Andrei R. Shustov, Jean Nichols, Susan Carroll, John Balser, Barbara Balser, Sarah McCue Horwitz	485
7	SUVmax reduction improves early prognosis value of interim positron emission tomography scans in diffuse large B-cell lymphoma 2011 ·Blood ·Olivier Casasnovas, Michel Meignan, Alina Berriolo-Riedinger, Stéphane Bardet, Anne Julian, Catherine Thiéblemont, Pierre Véra, Serge Bologna, Josette Brière, Jean-Philippe Jaı̈s, Corinne Haïoun, Bertrand Coiffier, Franck Morschhauser	216
8	Pralatrexate in Patients With Relapsed or Refractory Peripheral T-Cell Lymphoma: Results From the Pivotal PROPEL Study breakdown → 2011 ·Journal of Clinical Oncology ·Owen A. O’Connor, Barbara Pro, Lauren Pinter‐Brown, Nancy L. Bartlett, Leslie Popplewell, Bertrand Coiffier, Mary Jo Lechowicz, Kerry J. Savage, Andrei R. Shustov, Christian Gisselbrecht, Eric D. Jacobsen, Pier Luigi Zinzani, Richard R. Furman, André Goy, Corinne Haïoun, Michael Crump, Jasmine Zain, Eric D. Hsi, Adam P. Boyd, Steven M. Horwitz	439
9	Lymphoma Recurrence 5 Years or Later Following Diffuse Large B-Cell Lymphoma: Clinical Characteristics and Outcome 2010 ·Journal of Clinical Oncology ·Jean-François Larouche, Françoise Berger, Catherine Chassagne‐Clément, Martine Ffrench, Evelyne Callet‐Bauchu, Catherine Sebban, Hervé Ghesquières, Florence Broussais‐Guillaumot, Gilles Salles, Bertrand Coiffier	92
10	Safety, Pharmacokinetics, and Preliminary Clinical Activity of Inotuzumab Ozogamicin, a Novel Immunoconjugate for the Treatment of B-Cell Non-Hodgkin's Lymphoma: Results of a Phase I Study 2010 ·Journal of Clinical Oncology ·Anjali S. Advani, Bertrand Coiffier, Myron S. Czuczman, Martin Dreyling, James M. Foran, Eva Giné, Christian Gisselbrecht, Nicolas Ketterer, Sunita D. Nasta, A. Z. S. Rohatiner, Ingo G.H. Schmidt‐Wolf, Martin Schüler, Jorge Sierra, Mitchell R. Smith, Gregor Verhoef, Jane N. Winter, Joseph Boni, Erik Vandendries, Mark Shapiro, Luis Fayad	255
11	Long-term outcome of patients in the LNH-98.5 trial, the first randomized study comparing rituximab-CHOP to standard CHOP chemotherapy in DLBCL patients: a study by the Groupe d'Etudes des Lymphomes de l'Adulte breakdown → 2010 ·Blood ·Bertrand Coiffier, Catherine Thiéblemont, Éric Van Den Neste, G. Lepeu, Isabelle Plantier, Sylvie Castaigné, Sophie Lefort, Gérald Marit, Margaret Macro, Catherine Sebban, Karim Belhadj, Dominique Bordessoule, Christophe Fermé, Hervé Tilly	1071
12	Immuno–Fluorescence In Situ Hybridization Index Predicts Survival in Patients With Diffuse Large B-Cell Lymphoma Treated With R-CHOP: A GELA Study 2009 ·Journal of Clinical Oncology ·Christiane Copie‐Bergman, Philippe Gaulard, Karen Leroy, Josette Brière, Maryse Baia, Jean-Philippe Jaı̈s, Gilles Salles, Françoise Berger, Corinne Haïoun, Hervé Tilly, Jean‐François Emile, Alison H. Banham, Nicolas Mounier, Christian Gisselbrecht, Pierre Feugier, Bertrand Coiffier, Thierry Jo Molina	84
13	Long-Term Follow-Up of Patients With Newly Diagnosed Follicular Lymphoma in the Prerituximab Era: Effect of Response Quality on Survival—A Study From the Groupe d'Etude des Lymphomes de l'Adulte 2009 ·Journal of Clinical Oncology ·Emmanuel Bachy, Pauline Brice, Richard Delarue, Nicole Brousse, Corinne Haïoun, Steven Le Gouill, Alain Delmer, Dominique Bordessoule, Hervé Tilly, Bernadette Corront, Christian Allard, Charles Foussard, André Bosly, Bertrand Coiffier, Christian Gisselbrecht, Philippe Solal‐Céligny, Gilles Salles	50
14	Impact of Rituximab and/or High-Dose Therapy With Autotransplant at Time of Relapse in Patients With Follicular Lymphoma: A GELA Study 2008 ·Journal of Clinical Oncology ·Catherine Sebban, Pauline Brice, Richard Delarue, Corinne Haïoun, Bertrand Souleau, Nicolas Mounier, Nicole Brousse, Pierre Feugier, Hervé Tilly, Philippe Solal‐Céligny, Bertrand Coiffier	97
15	Safety and efficacy of ofatumumab, a fully human monoclonal anti-CD20 antibody, in patients with relapsed or refractory B-cell chronic lymphocytic leukemia: a phase 1-2 study 2007 ·Blood ·Bertrand Coiffier, Stéphane Leprêtre, Lars Møller Pedersen, Ole Gadeberg, (unknown), Marinus H. J. van Oers, James E. Wooldridge, Janusz Kłoczko, Jerzy Hołowiecki, Andrzej Hellmann, Jan Walewski, Mimi Folden Flensburg, Jørgen Holm Petersen, Tadeusz Robak	287
16	Standard chemotherapy with interferon compared with CHOP followed by high-dose therapy with autologous stem cell transplantation in untreated patients with advanced follicular lymphoma: the GELF-94 randomized study from the Groupe d'Etude des Lymphomes de l'Adulte (GELA) 2006 ·Blood ·Catherine Sebban, Nicolas Mounier, Nicole Brousse, Coralie Bélanger, Pauline Brice, Corinne Haïoun, Hervé Tilly, Pierre Feugier, (unknown), Chantal Doyen, Gilles Salles, Bertrand Coiffier	162
17	Final results of the efficacy and safety of rasburicase (recombinant urate oxydase) for the prevention and treatment of hyperuricemia in patients with aggressive lymphoma (GRAAL 1 study). 2002 ·Blood ·Bertrand Coiffier, Nicolas Mounier, Serge Bologna, Christophe Fermé, Raoul Herbrecht, H Tilly, Anne Sonet, B. Christian, Olivier Casasnovas, Éric Jourdan, Karim Belhadj	4
18	Late intensification is superior to early intensification in relapsing/refractory aggressive non-Hodgkin's lymphoma. A randomized study from the GELA: LNH RP93. 1997 ·Experimental Hematology ·André Bosly, Anne Sonet, Gilles Salles, P. Brice, Corinne Haïoun, (unknown), Hervé Tilly, P Lederlin, Isabelle Plantier, Catherine Sebban, Bertrand Coiffier	1
19	Alternance of chemotherapy does not improve results in aggressive non-Hodgkin's lymphoma: A prospective randomized study on 884 patients LNH87 protocol group 3: A gela study 1996 ·British Journal of Haematology ·André Bosly, Éric Lepage, Bertrand Coiffier, Brigitte Dupriez, Raoul Herbrecht, Georges Fillet, Marine Diviné, C. Nouvel, Hervé Tilly, Dominique Bordessoule, Philippe Gaulard, C Gisselbrecht	2
20	Consensus Conference on Intensive Chemotherapy Plus Hematopoietic Stem-Cell Transplantation in Malignancies: Lyon, France, June 4-6, 1993. 1994 ·Journal of Clinical Oncology ·Bertrand Coiffier, Thierry Philip, Alan K. Burnett, Michel Symann	30

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact